AUGUSTA PHARMACEUTICALS, INC.

Basic Information

58 OAK CLIFF RD
NEWTONVILLE, MA, 02460-

Company Profile

n/a

Additional Details

Field Value
DUNS: 828453139
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. DEVELOPMENT OF ROS KINASE INHIBITORS- PHASE I SBIR TOPIC 255

    Amount: $203,208.00

    The Augusta founding laboratories have used cutting edge genetic technologies and shRNA screening methodologies to uncover the ROS receptor tyrosine kinase as a cancer survival gene. Studies from othe ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government